Beonchip logo
Apr 13, 2020

Boston calling!

Next month, we are traveling to Boston for three weeks as part of the Richi Entrepreneurs program. This program helps companies from around the world establish themselves in the USA, focusing on Massachusetts, one of the country’s most dynamic areas, particularly for biotech companies. Through this program, Richi Entrepreneurs assigns each participant a mentor to guide them in identifying potential clients, investors, and clusters. Additionally, they organize seminars to explain key differences between Europe and America in areas such as business culture, patents, and required certifications.

Over the past few years, Richi Entrepreneurs has delivered impressive results through its programs. They have supported 37 impact start-ups and 71 entrepreneurs. Of these, five companies have already established operations in Boston, and ten more plan to do so soon. Notably, five entrepreneurs from the program have been named “Under 35” by MIT Tech Review—a recognition that our R&D Manager, Rosa, has also earned.

Impact for Beonchip

For Beonchip, this trip presents an incredible opportunity to validate our technology in what is arguably the world’s largest Organ-on-Chip hub. Boston is home to major players in the field, such as Emulate, and numerous researchers at MIT and Harvard are actively working on this topic. Meeting these world leaders and receiving their feedback will be invaluable for refining our technology and expanding our network.

We can undertake this trip with the support of Conetic (Confederación Española de Empresas de Tecnología de la Información y Electrónica). They identified us as one of the Spanish companies that could stand out in this year’s program. Furthermore, we are proud to be the first company from our region, Aragón, to participate in Richi Entrepreneurs. We hope this experience will significantly contribute to our growth and future success as a company.

If you want to learn more about our trip, be sure to check our website in the coming weeks for updates.

BOSTON CALLING!

 

Volatile organic compound detection in vitro as biomarkers of tumor progression

Summary This paper describes the use of our Be-Gradient Barrier-Free device to simulate the ischemic conditions present in solid tumors, enabling the study of volatile organic compounds (VOCs) as biomarkers for tumor progression . This approach marks a notable...

Microfluidic chip design customization guide for optimal cell culture

Summary This guide summarizes Beonchip’s microfluidic chip design customization options to improve your cell culture model. It highlights the importance of channel dimensions in microfluidic chips for key aspects such as cell culture area, microscopy inspection, and...

Gravity-driven flow importance in Organ-on-chip applications

Summary Gravity-driven flow is paramount during the first stages of culture in organ-on-chip platforms. This study demonstrates oxygen consumption in a cellular monolayer within a microfluidic device and highlights the significance of gravitational-flow in maintaining...

Bioprinting in organ-on-chip applications

Summary Over the past few years, bioprinting has emerged as a compelling field of study. The field of organ-on-chip has particularly benefited from bioprinting applications, offering novel pathways to enhance in vitro cell culture methods. This technical note explores...

A microphysiological system for handling graphene-related materials under flow conditions

Summary Researchers from the University of Castilla la Mancha and University of Zaragoza have optimized a kidney-on-chip for graphene particle testing. The microfluidic system was placed under flow conditions to reduce the adsorption of graphene materials on the...

Improving cell-cell and cell-matrix contact area with custom designs of the Be-Transflow device

Summary At Beonchip, we provide standard cell culture platforms and the option to customize the channel dimensions or membrane pore size. Additionally, we offer services to adapt the device design for specific research needs. In this note, we’ll summarize the results...

Be-Gradient as a blood-brain barrier model

Summary Here we provide a comprehensive and brief overview of a scientific publication detailing the developmental journey of the Be-Gradient Barrier-Free device. In it, we elucidate its intricate design process and rigorous testing procedures in a collaborative...

Cell fixation, staining and immunostaining in a chip.

Introduction Protocols such as immunostaining on a chip are frequently searched for, at the moment. Cell fixation and immunostaining are critical techniques in cell biology and biomedical research. Cell fixation is the process of immobilising cells in a particular...

Be-Transflow device as an epithelium-on-a-chip model for permeability studies

Researchers from the University of Zaragoza have employed a Beonchip microfluidic device to develop a stratified epithelia-on-a-chip model, showcasing the Be-Transflow as an epithelium-on-chip model for permeability studies.Figure 1 Be-Transflow device. Introduction...

Organoids-on-chip

In this note, we summarise the possible combination of two technologies, organoids and microfluidic devices, in what is also known as organoids-on-chip. What is an organoid and why use it in research? There has been an increasing shift towards the development of 3D...
Loading...